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Prospective medium-term results 
of multimodal pain management in 
patients with lumbar radiculopathy
A. Benditz1, M. Madl2, M. Loher3, J. Grifka1, D. Boluki1 & O. Linhardt4
Lumbar radiculopathy is one of the most common diseases of modern civilisation. Multimodal pain 
management (MPM) represents a central approach to avoiding surgery. Only few medium-term results 
have been published in the literature so far. This study compared subjective and objective as well as 
anamnestic and clinical parameters of 60 patients who had undergone inpatient MPM because of 
lumbar radiculopathy before and 1 year ±2 weeks after treatment. The majority of patients were very 
satisfied (35%) or satisfied (52%) with the treatment outcome. Merely 8 patients commented neutrally 
and none negatively. The finger-floor distance had decreased significantly (p < 0.01), and 30 patients 
(50%) had shown improved mobility of the spine after therapy. The need for painkillers had also been 
significantly reduced after 1 year. The arithmetical average of pain on a visual analogue scale was 7.21 
before treatment, which had significantly decreased to 3.58 at follow-up (p < 0.01). MPM is an effective 
approach for treating lumbar radiculopathy by mechanical nerve root irritation. Therefore, in the 
absence of an absolute indication for surgery or an absolute contradiction for MPM, patients should first 
be treated with this minimally invasive therapy.
In modern societies, lumbar radiculopathy and sciatica have become an increasing problem. Although all age 
groups are affected, elderly people are the largest population presenting with lumbar spine diseases. Lumbar 
radiculopathy may be caused by a herniated disc, disk protrusion or sciatica. Irritation or compression of the sci-
atic nerve often results in radicular pain along a specific dermatome and pseudoradicular pain. Such pain is often 
associated with claudicatio spinalis which decreases walking distances.
Finding the right treatment is important to these patients, and surgery should only be considered as a last 
resort. On the other hand, long-term pain must also be avoided to prevent pain chronification. Most of the many 
conservative treatment options available are not standardised and thus difficult to compare. For lumbar radicular 
pain syndrome, injections are an important treatment modality for reducing the irritation of affected anatomical 
structures1,2. Injection therapy is often accompanied by multimodal treatment such as physical therapy and psy-
chological counselling. Over the past years, multimodal pain management (MPM) consisting of inpatient injec-
tion therapy has been improved by the results obtained in new trials and by the growing experience of physicians3. 
MPM has been shown to be a very beneficial treatment option for avoiding surgery in patients with radicular 
nerve route compression4–6. Therefore, all conservative treatment options should be explored in the absence of an 
absolute indication for surgery1,7.
Aim of the study
The study aimed at proving the positive mid-term effect of a multimodal inpatient therapeutic concept based on 
drug injections for patients with lumbar radiculopathy.
Methods
This clinical study with a non-randomised unblinded prospective design included male and female patients with 
lumbar radiculopathy aged 29 to 79 years who had been treated according to a multimodal therapeutic concept at 
the Department of Orthopaedics of the University Medical Centre Regensburg between April 2009 and May 2010. 
Participation in the study was voluntary. Inclusion criterion was radicular pain arising from one specific nerve 
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root diagnosed by the presence of either the Lasègue sign, pain radiating distal to the knee or clearly attributable 
motoric failure. In addition, patients had to have participated in at least five psychological sessions during therapy. 
A clear indication for MPM had to exist, and an absolute indication for surgery had to be excluded.
Exclusion criteria were post-discectomy syndrome, rheumatic or inflammatory spinal disorders, tumours with 
spinal involvement and congenital spinal deformities. For ethical reasons, no control group was formed because 
such patients would have received placebo injections instead of the effective drugs. The study was approved by the 
Ethics Commission of the University of Regensburg (21.04.2010, Aktenzeichen 10-101-0061) and carried out in 
accordance to approved guidelines of the Helsinki Declaration of 1975. A written informed consent was obtained 
from all subjects. The study is registered in the DRKS with number DRKS00010257 (WHO register).
Patients. 88 of initially 285 patients remained after evaluation of the patient files for exclusion criteria. After 
a telephone interview, further 28 patients were excluded, so that 60 volunteers remained in the study (Fig. 1, 
Table 1).
Intervention. The duration of the treatment was 8–12 days (mean 10.8 days) for every patient. On average, 
each patient received two injections daily, one in the morning and one at noon. The injections are lumbar spinal 
nerve root analgesia (LSPA) of the affected nerve root in ‘freehand technique’8 Additional treatment consisted of 1 
injection of the facette joints under x-ray and 1 epidural injections in ‘loss-of-resistance technique’ per stay. LSPA 
injections only contained 0.5% Scandicaine, whereas epidural injections and facette joint injection also contained 
triamcinolone 40 mg (Table 2)3,9–11. In cases of good effect the injection was repeated once.
Physiotherapy and sports therapy as part of inpatient MPM includes group exercises and aqua training; 
accompanying measures consist of electrotherapy for muscle relaxation and thermotherapy. In addition, patients 
are instructed in progressive muscle relaxation according to Jacobsen and take part in coordination training. 
Figure 1. Flowchart of patient inclusion. 
Female (n = 26) Male (n = 34) Together
Age (years) 56,35 (33–77) 51,15 (29–79) 53,40 (29–79)
Height (centimetres) 163,56 (156–173) 177,42 (156–195) 172,53 (156–195)
Weight (kilogram) 76,44 (55–105) 90,80 (69–125) 85,74 (55–125)
BMI 28,55 (21,48–37,80) 28,66 (23,14–40,49) 28,62 (21,48–40,49)
Table 1.  Antropometric data of the patient group (mean and range).
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The most effective exercises are isometric exercises for strengthening the back muscles, which is further aided by 
medical training therapy with workout equipment. The main goal is recovery of the load-bearing capacity and 
reduction in pain-avoidance behaviour. The success of MPM depends on accurate patient information and con-
sultation, continuous motivation, a systematic increase of load and permanent feedback12.
The psychotherapeutic programme of multimodal pain management13 consists of an individual interview, 
but mainly of group therapy. Group therapy aims at motivating group members by introducing a new patient to 
the group discussion, thus raising the awareness of all group members. All patients have to keep a pain diary. The 
benefits of these therapy elements are well documented14–16. The aim is to mediate disease-specific information, 
promote health and vitality and decrease psychophysical activation by stress factors, especially pain (Table 3)17.
Follow-up. Data were recorded in standardised form at baseline and at the 1-year follow-up. The data 
obtained before and after treatment were compared to assess treatment success. The data provided information on 
the length and extent of the treatment success 1 year (± 2 weeks) after hospitalisation. Physical and psychological 
factors were evaluated by means of the Oswestry Disability Index (ODI), the Short Form-36 (SF-36), the numer-
ical rating scale of pain (NRS) and the Hospital Anxiety and Depression Scale (HADS-D). A detailed medical 
history and clinical examination of the patient completed the data for the assessment.
Statistical analysis. Data were compared with the t-test for paired variables and the non-parametric 
Wilcoxon test. The level of significance was set at p < 0.05. Statistical analysis was done with the programme SPSS 
19.0 by IBM® .
Results
In all patients, the diagnosis of lumbar radiculopathy was made by means of patient history and clinical symp-
toms prior to treatment. For 59 patients, an additional clinically relevant finding was detected in the MRI 
(VA herniation or protrusion). Only 1 patient had no radiological finding corresponding to the symptoms but still 
met the indication for MPM. As expected, L4/L5 was the most commonly affected site in our study population 
(Table 4).
Pain. The mean NRS value was 7.2 before treatment, 2.4 at discharge and 3.6 at follow-up, as shown in Fig. 2. 
100% of the patients showed a short-term reduction and 87% a mid-term reduction in NRS values and therefore 
in pain (Fig. 2).
Dividing patients into age groups on average shows lower NRS values for younger patients at follow-up 
(Fig. 3).
Flexibility. Finger-floor distance had significantly improved from a mean of 20.92 cm (SD: 18.921) before 
treatment to 10.1 cm (SD: 12 097) at the 1-year follow-up (p < 0.05). Another spinal mobility measure is testing 
the motion directions to detect any mobility restrictions. At the initial examination, 37 patients showed mobility 
restriction in at least one direction. This figure was significantly reduced to 18 patients at follow-up (p < 0.05).
Minimum Maximum Average Standard deviation
LSPA 10 24 17,75 2,634
Epidural injections 0 5 1,7 0,809
Facette injections 0 3 1,13 0,769
Iliosacral joint injection 0 3 0,22 0,585
Table 2.  Overview of injections.
exercise number
Group exercises 4
Aqua training 7
back exercises 5
Instructions for progressive muscle relaxation 3
Coordination training group 4
Table 3.  Example of a 10-day schedule of physiotherapy and sports therapy as part of inpatient MPM.
Nerve root L2 L3 L4 L5 S1
absolute frequency 2 1 6 34 17
Frequency in percent 3,3% 1,7% 10% 56,7% 28,3%
Table 4.  Frequency distribution of the affected nerve root at the start of treatment.
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Senso-Motoric Development. Motor deficits in the sense of serious paresis such as foot drop were not 
included here because such deficits represent an indication for surgical treatment, which would have resulted 
in the withdrawal from the study. At the initial examination, 10 patients had motor deficits in terms of reduced 
strength (3/5 or 4/5) but none at follow-up. This difference is significant (p < 0.05). Sensory deficits such as hypo-
sensitivity or paraesthesia were reduced from 25 to 17. 14 patients still experienced hyposensibility at different 
degrees, and 3 patients had paraesthesia. The number of complaint symptoms could also be reduced, and, accord-
ing to the hypothesis, the difference was statistically significant in a one-sided test (p < 0.05). Thus, MPM reduced 
motor and sensory deficits as well as pain and accompanying symptoms.
Questionnaires. The Oswestry Disability Index (ODI) is used to measure everyday impairment. The mean 
value in our patients at the initial examination was 38.95% and 22.83% at follow-up, hence the reduction was 
significant (p < 0.05). In addition, the frequency of category ‘0% to 10%’ could be increased from 0 at baseline to 
16 at follow-up. The Hospital Anxiety and Depression Scale (HADS-D) was additionally used to detect possible 
psychological impairment and to gain a comprehensive picture of a patient’s situation. No significant difference 
was found, only a slight decrease in the positive results. Nevertheless, 4 positive results were found at follow-up. 
Patients with a positive anxiety value often also showed a positive depression value. Thus, only a few patients had 
slightly elevated results in the HADS-D (n = 8 before treatment, n = 8 after treatment).
The Short Form 36 (SF-36) was used in addition to the ODI and the HADS-D. The SF-36 and the ODI not only 
record physical impairment but – similar to the HADS-D − also issues of mental health. Thus, only the following 
3 parameters were used when evaluating the SF-36: ‘subjectively experienced current state of health’, ‘current 
impairment’, which was categorized, and ‘health status compared to last year’. The information given on the per-
ceived health status showed its development from the initial examination to follow-up. The median of this topic 
had significantly changed from ‘less well’ at baseline to ‘good’ at follow-up (p < 0.05). As already indicated by the 
ODI, even everyday impairment could be significantly reduced (p < 0.05). The majority of patients (n = 37; 63%) rated 
their own health as improved, and only 8 patients considered their own health deteriorated over the previous 
Figure 2. Mean values of NRS at admission, after discharge and at 1-year follow-up. 
Figure 3. Mean NRS values according to age group. 
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year. However, some of these patients had developed other diseases and traumas such as a femoral neck fracture 
in addition to their back problems.
Patient Satisfaction. At follow-up, patients were asked how satisfied they were with the success of 
their treatment and the treatment plan. 35% of patients (n = 21) were very satisfied, 52% (n = 31) were satis-
fied and 13% (n = 8) had an impartial attitude regarding the success and concept of the treatment. If required, 
most patients would repeat the therapy and recommend the treatment. Patients who did not reach the desired 
medium-term treatment outcome did still not view the treatment in a negative manner because the initial pain 
relief was perceived as very positive. In addition, patients had perceived the treatment and care within the MPM 
concept as very good and pleasant.
Discussion
Discogenic disorders mostly occur at certain levels of the spine. Segments L4/5 and L5/S1 and their respective 
nerve roots, for instance, are mostly stressed mechanically and therefore most commonly affected18. This fact 
could also be seen in the patients of this study. The nerve roots L4 (10%), L5 (56.7%) and S1 (28.3%) were affected 
corresponding to the pathological findings at the described levels. A similar distribution was also shown in a 
study by Carette et al.19. Here, the L4 dermatome was affected in 13% and the L5 dermatome in 46.2% of the cases. 
Many studies have shown the high potential for spontaneous remission20,21.
As conservative treatment options usually only single methods are compared. There are either only injec-
tions22 or different types of physiotherapy23 compared to surgery or waiting for remission because of natural 
history. All these single methods need more time for a longer lasting success. Especially injections alone are 
known for only short term success24. Another problem is the low frequency of treatment for outpatient patients. 
Therefore, it takes longer to have the first pain relief and there is a high danger to have pain chronification.
There we see the big advantage of MPM. Patients get a lot of different conservative treatment methods in a 
very short time period. This leads to a quick pain relief and in combination with the psychological lessons avoids 
chronification.
In contrast to former opinions, today pain management and physical activation are the centre of conservative 
treatment. The aim of the accompanying methods is to preserve or restore the full capacity of the spine-stabilizing 
muscles, to train coordination skills and to learn spine friendly behaviour. Risk factors that can lead to chronic 
pain must be eliminated. All methods serve to interrupt the vicious circle of “pain - stress - malposition- pain”.
The injections help to reduce pain as fast as possible25,26. Then patients can take part in activating treatments 
like back exercises or aqua training more intensively due to reduced pain. Beside direct physical effects the accom-
panying therapies also help to improve the affective-emotional level as well as the motor-psychomotor level by 
learning physically regulating movements. The focus is on activating methods, not on passive methods.
So chronification can be avoided and when being back in daily life, the patient has new possibilities to avoid 
falling back into the vicious circle of pain and has the positive feeling that there are always treatment options to 
reduce pain. For us this is the reason for the very good med-term effects of the MPM.
The variety of pain scores used in the different treatment concepts makes a comparison with other studies 
difficult. Even comparisons within one and the same study are often not possible because answers are always sub-
jective assessments, although items are objectified by pain scales. Thus, only comparisons are useful that include 
the scores before and after treatment and that are carried out for each individual patient. In the present study, a 
numerical pain scale was used, and its classification ranged from 1 to 10. The initial examination yielded values 
between  4 and 10 and an average value of 7.2. At discharge, the values ranged between 0 and 6, and the average 
value was significantly reduced to 2.4 (p < 0.05). All patients experienced at least temporary pain reduction. At 
the 1-year follow-up, values ranged between 0 to 10, and the average value was 3.6, which showed significant pain 
reduction (p < 0.05). Particularly younger patients had lower NRS values  in the follow-up, thus benefited most 
from MPM. This finding is probably due to the fact that younger patients are not yet affected by degenerative 
changes, which are likely to contribute to pain symptoms.
Ultimately, the pain symptoms of the patients in the present study could be reduced on average by 50%. 
However, because a ordinal scale was used in this study, it cannot be assumed that average pain intensity was 
halved. Spinal mobility was determined by means of finger-floor distance and movement restrictions according 
to active and passive mobility. However, not only restricted mobility of the lumbar spine may impede finger-floor 
distance but also shortened hamstrings and limited hip function. Nevertheless, a radiological study showed a 
valid connection between finger-floor distance and lumbar spinal mobility27. Finger-floor distance had signifi-
cantly decreased to 10.10 cm on average at follow-up in contrast to 20.92 cm at the initial examination (p < 0.05).
Passive and active mobility provides more information on spinal mobility and possible spinal injury. 
Examinations test lateral flexion and rotation as well as restrictions in inclination and reclination angles which are 
often impeded in the presence of lumbar pain. At the initial examination, 62% of the patients in the current study 
had restricted mobility in at least one direction. Until follow-up, this figure could be reduced to 30% (p < 0.05). 
Thus, a significantly lower value (p < 0.05) was achieved in both mobility restriction and finger-floor distance.
The case-control study by Thomas et al.28 showed a significant correlation between back pain and reduced spi-
nal mobility. The group of patients with back pain had significantly worse spinal mobility than the control group. 
The collected data of the present study could also show this correlation. The spinal mobility of patients could be 
considerably improved by MPM.
In addition to pain, patients are particularly affected by motor and sensory deficits. For this reason, attention 
should also be focussed on these complaints, although they are usually not a patient’s prime concern. Pain and its 
treatment are usually the most important issues for affected patients. At baseline, 10 patients of the present study 
had a motor deficit such as minor reduction in strength that did not indicate surgery. At follow-up, none of the 
patients had any motor skill problems. Thus, motor deficits could be reduced by 100%, which it is a significant 
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result (p < 0.05). In addition, 25 patients had complained about sensitive deficits at baseline. At follow-up, this 
figure was reduced to 17. 14 patients still experienced hyposensibility at different degrees, and 3 patients had par-
aesthesia. However, these deficits were only intermittent. Of further significance is also the successful treatment 
of symptoms in 8 patients (p < 0.05). MPM resulted in significant pain relief (p < 0.05) as well as in decreased 
accompanying motor and sensory deficits. A similar development was also found by Madl et al.1. The Oswestry 
Disability Index (ODI) serves to objectify everyday impairment, thus values  between 0% and 100% are possible. 
The higher the value, the higher is the impairment in everyday life. In the present study, ODI was collected at 
baseline and at follow-up. At the time of discharge, no ODI data were collected. The mean value at the initial 
examination was 38.95% and 22.83% at follow-up, hence the reduction was significant (p < 0.05). In addition, the 
frequency of category ‘0% to 10%’ could be increased from 0 at baseline to 16 at follow-up. Besides pain reduc-
tion, the limitations in daily life could be also be reduced, mainly because of the strong correlation between pain 
and impairment in daily life. Lumbar radiculopathy impedes everyday actions such as getting dressed. A decrease 
in pain therefore reduces everyday impairment. The concept of MPM takes advantage of this fact by starting 
physiotherapeutic exercises at this point.
The SF-36 questionnaire was used in addition to the ODI and the HADS-D because it measures both physical 
and psychological impairment. Therefore, only the following three parameters were used: ‘subjectively experi-
enced current state of health’, ‘current impairment’, which was categorized, and ‘health compared to last year’. 
The patients’ current health status was documented in categories. The median had changed from ‘less good’ to 
‘good’ from the first examination to the follow-up. Categorized impairment showed of course a similar pattern 
of that already provided by the ODI. Again, the number of patients with severe to very severe impairment had 
been reduced from 10 to 4. At the same time, the number of patients with little or no impairment had significantly 
increased from 3 to 26. Patients were also asked about the development regarding their general state of health. 
63% of patients felt better 1 year after the therapy than at the beginning. Only 14% of patients reported deteri-
oration in health. However, since this question included the development of general health and not just of back 
problems, the informative value of this parameter regarding therapeutic success is limited. For example, some 
patients had meanwhile been diagnosed with an internal disease or with a femoral neck fracture.
Subjective patient satisfaction reflects very well how obtained results correspond with patient demands and 
expectations. So what do patients demand and expect from this treatment method? Demands and expectations 
may range from pain relief to slight improvement to maintaining the current health status. In the present study, 
35% of patients were very pleased, 52% were pleased and 13% had an impartial attitude regarding the success and 
concept of the treatment. These figures may seem at first a bit surprising, as some patients still experience pain, 
partly also of higher intensity than before the treatment. Nevertheless, none of the patients commented nega-
tively on the treatment which may be due to several reasons. As already mentioned, patient satisfaction crucially 
depends on patient expectation. Even small improvements of often short duration may already be perceived as 
positive, thus influencing patient satisfaction. Furthermore, the care provided, the detachment from the chal-
lenges of daily life and the related psychological relief may be perceived as positive by the patients5. These factors 
were stated by many patients in the current study. Despite attempts to exclude any iatrogenic influence, patients 
may have been somewhat influenced when answering this question because of the principle of social desirability.
Conclusion
The lack of a control group is a limiting factor of the study. But evaluating the overall concept of MPM and not 
just the sub-item of injections makes the implementation of a control group difficult. Moreover, study populations 
may show a trend towards chronic back problems because the admission requirement of inpatient multimodal 
therapy is the failure of outpatient unimodal therapy. Despite these limitations, this study yielded satisfactory 
results. Treating radicular pain by inpatient MPM based on injections still shows an average pain reduction by 3.6 
points 1 year after therapy. The positive picture is completed by the subjective impression of the patients: 87% of 
the patients were satisfied or very satisfied with the treatment. 87% of the patients achieved medium-term pain 
relief. Finally, 12.98% of all treated patients had to be operated on during the observation period because of radic-
ular and pseudoradicular complaint pathologies. In addition, no serious complications were observed.
In summary, MPM based on injections is an effective and low-risk treatment option for lumbar radiculopathy. 
In the absence of an absolute indication for surgery or an absolute contraindication for MPM, patients with lum-
bar radiculopathy should be first treated with this minimally invasive intervention.
Ethical approval and informed consent. The study was approved by the Ethics Commission of the 
University of Regensburg and carried out in accordance with the approved guidelines. Registration in DRKS 
number DRKS00010257.
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